Camila T. Franca

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Mechanistic and antigenic boundaries of Henipavirus and Parahenipavirus glycoproteins.

Mechanistic and antigenic boundaries of Henipavirus and Parahenipavirus glycoproteins.

Journal: Nature communications
Published: September 17, 2025

Yeast Display Reveals Plentiful Mutations That Improve Fusion Peptide Vaccine-Elicited Antibodies Beyond 59% HIV-1 Neutralization Breadth.

Yeast Display Reveals Plentiful Mutations That Improve Fusion Peptide Vaccine-Elicited Antibodies Beyond 59% HIV-1 Neutralization Breadth.

Journal: Vaccines
Published: September 02, 2025

Correction: An antibody screen of a Plasmodium vivax antigen library identifies novel merozoite proteins associated with clinical protection.

Correction: An antibody screen of a Plasmodium vivax antigen library identifies novel merozoite proteins associated with clinical protection.

Journal: PLoS neglected tropical diseases
Published: May 22, 2025

High-Throughput Antibody Neutralization Screening in Massively Parallel Droplet Arrays.

High-Throughput Antibody Neutralization Screening in Massively Parallel Droplet Arrays.

Journal: bioRxiv : the preprint server for biology
Published: February 20, 2025

The essential malaria protein PfCyRPA targets glycans to invade erythrocytes.

The essential malaria protein PfCyRPA targets glycans to invade erythrocytes.

Journal: Cell reports
Published: July 27, 2023

Development of at-home sample collection logistics for large-scale seroprevalence studies.

Development of at-home sample collection logistics for large-scale seroprevalence studies.

Journal: PloS one
Published: July 27, 2021

Naturally acquired blocking human monoclonal antibodies to Plasmodium vivax reticulocyte binding protein 2b.

Naturally acquired blocking human monoclonal antibodies to Plasmodium vivax reticulocyte binding protein 2b.

Journal: Nature communications
Published: May 25, 2020

Antibodies to Plasmodium vivax reticulocyte binding protein 2b are associated with protection against P. vivax malaria in populations living in low malaria transmission regions of Brazil and Thailand.

Antibodies to Plasmodium vivax reticulocyte binding protein 2b are associated with protection against P. vivax malaria in populations living in low malaria transmission regions of Brazil and Thailand.

Journal: PLoS neglected tropical diseases
Published: October 01, 2018

Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria.

Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria.

Journal: PLoS neglected tropical diseases
Published: May 25, 2018

IgG antibodies to synthetic GPI are biomarkers of immune-status to both Plasmodium falciparum and Plasmodium vivax malaria in young children.

IgG antibodies to synthetic GPI are biomarkers of immune-status to both Plasmodium falciparum and Plasmodium vivax malaria in young children.

Journal: Malaria journal
Published: August 02, 2017

Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development.

Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development.

Journal: eLife
Published: May 16, 2017

Naturally acquired antibody responses to more than 300 Plasmodium vivax proteins in three geographic regions.

Naturally acquired antibody responses to more than 300 Plasmodium vivax proteins in three geographic regions.

Journal: PLoS neglected tropical diseases
Published: April 27, 2017
Showing 1-12 of 16

Last Updated: 09/26/2026